UPA Nolvadex 35mg (Tamox)

UPA Nolvadex 35mg is an oral Selective Oestrogen Receptor Modulator (SERM) containing Tamoxifen, a compound used medically to influence oestrogen receptor activity. Each tablet contains a stated 35mg of Tamoxifen, supplied in a pack of 50 tablets.

Tamoxifen is widely recognised for its role in treating certain hormone-sensitive breast cancers. It works by blocking the effects of oestrogen in specific tissues while producing oestrogen-like effects in others.

What UPA Nolvadex 35 Is Used For

Tamoxifen is primarily associated with oestrogen receptor regulation and hormone-sensitive medical conditions.

• Breast Cancer Treatment: Used medically to treat certain oestrogen receptor-positive breast cancers.
• Oestrogen Receptor Regulation: Blocks oestrogen activity in selected tissues, particularly breast tissue.
• Gynaecomastia Management: Sometimes prescribed off-label to manage breast tissue enlargement in men.
• Hormonal Regulation: Influences feedback mechanisms involved in reproductive hormone production.
• LH and FSH Activity: May increase luteinising hormone (LH) and follicle-stimulating hormone (FSH) levels in certain individuals.
• Post-Cycle Therapy (PCT): Sometimes used non-medically following anabolic steroid exposure, although this application is not an established approved treatment.

How UPA Nolvadex 35 Works

Tamoxifen acts as a Selective Oestrogen Receptor Modulator (SERM), meaning its effects vary depending on the tissue involved.

• Oestrogen Receptor Blocking: Competes with oestrogen for receptor binding in certain tissues.
• Breast Tissue Activity: Reduces oestrogen-driven stimulation of susceptible breast cells.
• Selective Hormonal Effects: Can block oestrogen activity in some tissues while producing oestrogen-like effects in others.
• Hypothalamic Feedback: May alter oestrogen-related feedback mechanisms involved in reproductive hormone regulation.
• LH and FSH Regulation: Can influence pituitary hormone secretion in certain individuals.
• Testosterone Regulation: May indirectly increase endogenous testosterone production in some men through changes in hormonal feedback.

Unlike aromatase inhibitors, Tamoxifen does not directly prevent the conversion of testosterone into oestrogen.

Possible Side Effects

Tamoxifen may cause side effects related to its effects on oestrogen receptors and hormonal regulation.

Common or Recognised Side Effects:

• Hot flushes and increased sweating.
• Nausea or gastrointestinal discomfort.
• Headaches and dizziness.
• Fatigue or general weakness.
• Changes in mood.
• Fluid retention.
• Muscle cramps or joint discomfort.
• Changes in libido.
• Menstrual irregularities in women.